These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31134775)

  • 1. Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries – data from the ECEE network.
    Skrzat-Klapaczyńska A; Matłosz B; Otelea D; Harxhi A; Vassilenko A; Bolokadze N; Rüütel K; Papadopoulos A; Mardarescu M; Youle M; Kowalska JD; Horban A
    Przegl Epidemiol; 2019; 73(1):61-68. PubMed ID: 31134775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
    Kowalska JD; Bursa D; Gökengin D; Jilich D; Tomazic J; Vasylyev M; Bukovinowa P; Mulabdic V; Antonyak S; Horban A;
    HIV Med; 2018 Oct; 19(9):629-633. PubMed ID: 29989332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of occult HCV infection among Hiv infected patients in Georgia.
    Gatserelia L; Sharvadze L; Karchava M; Dolmazashvili E; Tsertsvadze T
    Georgian Med News; 2014 Jan; (226):37-41. PubMed ID: 24523330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report.
    Kowalska JD; Oprea C; de Witt S; Pozniak A; Gökengin D; Youle M; Lundgren JD; Horban A;
    HIV Med; 2017 May; 18(5):370-375. PubMed ID: 27553526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
    Al-Mughales JA
    J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of viral hepatitis care in 16 countries of Central and Eastern European Region.
    Chkhartishvili N; Holban T; Simonović Babić J; Alexiev I; Matičič M; Kowalska J; Horban A;
    Cent Eur J Public Health; 2019 Sep; 27(3):212-216. PubMed ID: 31580556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network Group.
    Aimla K; Kowalska JD; Matulionyte R; Mulabdic V; Vassilenko A; Bolokadze N; Jilich D; Antoniak S; Oprea C; Balayan T; Harxhi A; Papadopoulos A; Lakatos B; Vasylyev M; Begovac J; Yancheva N; Streinu-Cercel A; Verhaz A; Gokengin D; Dragovic G; Sojak L; Skrzat-Klapaczyńska A;
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
    Yang T; Chen Q; Li D; Wang T; Gou Y; Wei B; Tao C
    J Med Virol; 2018 Jan; 90(1):101-108. PubMed ID: 28792076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on the causes of death associated with combined effects of HBV and HCV infection in patients with acquired immunodeficiency syndrome].
    Guo PL; Cai WP; Chen XJ; He HL; Hu FY; Tang XP; Li LH
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):495-498. PubMed ID: 30317770
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients.
    Dimitrakopoulos A; Takou A; Haida A; Molangeli S; Gialeraki A; Kordossis T
    J Infect; 2000 Mar; 40(2):127-31. PubMed ID: 10841086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.
    Jansen K; Thamm M; Bock CT; Scheufele R; Kücherer C; Muenstermann D; Hagedorn HJ; Jessen H; Dupke S; Hamouda O; Gunsenheimer-Bartmeyer B; Meixenberger K;
    PLoS One; 2015; 10(11):e0142515. PubMed ID: 26555244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
    Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
    J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
    Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B & C virus infection in HIV seropositive individuals & their association with risk factors: A hospital-based study.
    Sharma V; Ramachandran VG; Mogha NS; Bharadwaj M
    Indian J Med Res; 2018 Jun; 147(6):588-593. PubMed ID: 30168491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.